Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III
- 1 September 2006
- journal article
- Published by Elsevier in Virus Research
- Vol. 120 (1-2) , 107-112
- https://doi.org/10.1016/j.virusres.2006.02.003
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- VENEZUELAN EQUINE ENCEPHALITISAnnual Review of Entomology, 2004
- Biological Weapons—a Primer for MicrobiologistsAnnual Review of Microbiology, 2001
- Bioterrorism: Implications for the Clinical MicrobiologistClinical Microbiology Reviews, 2001
- A simple device for the exposure of animals to infectious microorganisms by the airborne routeEpidemiology and Infection, 1997
- Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccineVaccine, 1996
- Update on the neutralisation of animal virusesReviews in Medical Virology, 1995
- In vitro mechanisms of monoclonal antibody neutralization of alphavirusesVirology, 1988
- TC‐83 Venezuelan equine encephalitis vaccine exposure during pregnancyTeratology, 1987
- The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopesVirology, 1985
- Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodiesVirology, 1982